相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial
Lu Lin et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation
Michael S. Garshick et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Statin therapy upregulates arachidonic acid status via enhanced endogenous synthesis in patients with plaque psoriasis
Michael S. Garshick et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2022)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial
Mohammad Al Salman et al.
DERMATOLOGIC THERAPY (2021)
The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial
Afroz Abidi et al.
INDIAN JOURNAL OF PHARMACOLOGY (2020)
Treatment with liraglutide, a glucagon-like peptide-1 analogue, improves effectively the skin lesions of psoriasis patients with type 2 diabetes: A prospective cohort study
Xiangjin Xu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Efficacy and safety of pioglitazone plus phototherapy versus phototherapy in patients with plaque type psoriasis: a Double Blinded Randomized Controlled Trial
Maryam Ghiasi et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2019)
Atorvastatin as adjunctive therapy for chronic plaque type psoriasis versus betamethasone valerate alone: A randomized, double-blind, placebo-controlled trial
Sharlene Helene H. Chua et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2017)
Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Surjit Singh et al.
BMC DERMATOLOGY (2016)
The efficacy of methotrexate plus pioglitazone vs. methotrexate alone in the management of patients with plaque-type psoriasis: a single-blinded randomized controlled trial
Vahide Lajevardi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Clinical effects of pioglitazone, an insulin sensitizing drug, on psoriasis vulgaris and its co-morbidities, a double blinded randomized controlled trialx1
Vanessa G. Hafez et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients-a randomized placebo-controlled trial
A. Faurschou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
A. Faurschou et al.
ACTA DIABETOLOGICA (2014)
Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study
M. Buysschaert et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Modulation of LXR-α and the effector genes by Ascorbic acid and Statins in psoriatic keratinocytes
Deepti Soodgupta et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Liraglutide in combination with acitretin for severe recalcitrant psoriasis
C. T. Reid et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study
T. Ahern et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Improvement of psoriasis during exenatide treatment in a patient with diabetes
M. Buysschaert et al.
DIABETES & METABOLISM (2012)
Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis
A. E. Hogan et al.
DIABETOLOGIA (2011)
Atorvastatin for the Treatment of Plaque-Type Psoriasis
Toktam Faghihi et al.
PHARMACOTHERAPY (2011)
Simvastatin in Psoriasis: Ambiguous Effects
Andreas Colsman et al.
ACTA DERMATO-VENEREOLOGICA (2010)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
ANNALS OF INTERNAL MEDICINE (2009)
Efficacy and Safety of Combination Acitretin and Pioglitazone Therapy in Patients With Moderate to Severe Chronic Plaque-Type Psoriasis
Rajan Mittal et al.
ARCHIVES OF DERMATOLOGY (2009)
Psoriasis in France and Associated Risk Factors: Results of a Case-Control Study Based on a Large Community Survey
P. Wolkenstein et al.
DERMATOLOGY (2009)
Efficacy of simvastatin in plaque psoriasis: A pilot study
Ivan Valeiyevich Shirinsky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone
Charles N. Ellis et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2007)
Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6)
N Shafiq et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2005)
Treatment of active psoriatic arthritis with the PPAR gamma ligand pioglitazone: an open-label pilot study
T Bongartz et al.
RHEUMATOLOGY (2005)
A clinical dilemma while treating hypercholesterolaemia in psoriasis
TC Jacobi et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
分享论文
